Henry Schein Names Frederick M. Lowery as Chief Executive Officer
Article excerpt
Highlighted: the sentence this signal was extracted from
Henry Schein names Frederick M. Lowery as Chief Executive Officer. MELVILLE, N.Y., January 12, 2026 - Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. Mr. Lowery brings more than two decades of healthcare expertise to Henry Schein, with a strong track record of scaling complex businesses to drive significant growth and sustained value creation. Most recently, he served as Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific (NYSE: TMO), leading the Fisher Scientific distribution channel's above-market performance. His experience growing distribution and owned product businesses - including manufacturing, R&D, marketing, and sales functions - closely aligns with Henry Schein's business model, positioning him well to guide the Company's next phase of growth and continued execution of its BOLD+1 strategic plan. "I am honored to join Henry Schein at such a pivotal moment. This is an...
Keep reading with a free account
The rest of this article, and every signal for Henry Schein, is in your free account.
